Pfizer Inc. Stock Market Performance Overview (February 4, 2026)
- Current Price: $25.77
- Previous Close: $26.66
- Change: -$0.89
- Percentage Change: -3.34%
- Opening Price: $25.36
- Intraday High: $26.11
- Intraday Low: $25.26
- Trading Volume: Approximately 9.19 million shares
- Total Market Capitalization: Approximately $146.52 billion
Intraday Price Movement Analysis
Pfizer's stock opened at $25.36, which was slightly below the previous day’s closing price of $26.66. Throughout the trading session, the price fluctuated between an intraday high of $26.11 and a low of $25.26, resulting in a trading range of $0.85.
The stock closed at $25.77, reflecting a decline of $0.89 or 3.34% compared to the previous close. This downward movement indicates a notable loss in investor confidence or reactions to broader market dynamics during the day.
Trading volume reached approximately 9.19 million shares, signaling an active trading day with significant liquidity. Pfizer’s market capitalization remains strong at around $146.52 billion, maintaining its status as a major pharmaceutical sector player.
Historical Price Context (Last Five Trading Days)
| Date | Closing Price ($) |
|---|---|
| February 3, 2026 | 26.66 |
| February 2, 2026 | 26.50 |
| February 1, 2026 | 26.75 |
| January 29, 2026 | 27.00 |
| January 28, 2026 | 27.10 |
Over the past week, Pfizer’s stock price has declined approximately 5%, dropping from a peak closing price of $27.10 on January 28 to $25.77 on February 4. This decline indicates a bearish trend among investors during this period.
Market News and Influencing Factors
There were no significant company-specific news releases or announcements concerning Pfizer on February 4, 2026. The absence of direct news suggests that Pfizer’s decline may be attributable to broader market influences rather than internal corporate developments.
Potential external factors affecting Pfizer's stock price include macroeconomic variables such as interest rate fluctuations, inflation concerns, or shifts in investor preferences between growth and value stocks. The healthcare sector's sensitivity to regulatory policies and drug pricing debates may also indirectly impact Pfizer’s stock.
Summary
On February 4, 2026, Pfizer Inc. experienced a significant single-day stock price decline of 3.34%, closing at $25.77. The stock showed intraday volatility within a range of $0.85 and traded actively with approximately 9.19 million shares exchanged. No company-specific news was reported, pointing to external market forces as primary drivers of the stock’s movement.
The recent downward price trend over the past week marks a shift in investor sentiment toward Pfizer, warranting continued observation to determine if this bearish momentum persists or reverses in upcoming sessions.
Explore more exclusive insights at nextfin.ai.